Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 03, 2018
Source ID
10.1038/s41388-018-0462-2

Entities

People

  • Akhilesh Kumar
  • Balaji T. Moorthy
  • Devang M. Patel
  • Fangliang Zhang
  • Isildinha M. Reis
  • Kerry L Burnstein
  • Laine M Heidman
  • Mark L. Gonzalgo
  • Merce Jorda
  • Michael D. Birnbaum
  • Ning Zhao
  • Oleksandr N. Kryvenko
  • William M. Morgan
  • Xi Chen
  • Yuguang Ban

Organizations

  • Congressionally Directed Medical Research Programs
  • National Institute of General Medical Sciences